EcoR1 Capital LLC 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-26 11:59 am Purchase |
2024-03-08 | 13G | Adaptimmune Therapeutics plc ADAP |
EcoR1 Capital LLC | 164,424,420 10.700% |
51,000,000 (+44.96%) |
Filing |
| 2024-01-30 5:26 pm Purchase |
2024-01-30 | 13G | Adaptimmune Therapeutics plc ADAP |
EcoR1 Capital LLC | 113,424,420 7.700% |
113,424,420 (New Position) |
Filing |